228 related articles for article (PubMed ID: 32011655)
1. Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy.
Labau JIR; Estacion M; Tanaka BS; de Greef BTA; Hoeijmakers JGJ; Geerts M; Gerrits MM; Smeets HJM; Faber CG; Merkies ISJ; Lauria G; Dib-Hajj SD; Waxman SG
Brain; 2020 Mar; 143(3):771-782. PubMed ID: 32011655
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.
de Greef BT; Merkies IS; Geerts M; Faber CG; Hoeijmakers JG
Trials; 2016 Jun; 17(1):306. PubMed ID: 27363506
[TBL] [Abstract][Full Text] [Related]
3. Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial.
de Greef BTA; Hoeijmakers JGJ; Geerts M; Oakes M; Church TJE; Waxman SG; Dib-Hajj SD; Faber CG; Merkies ISJ
Brain; 2019 Feb; 142(2):263-275. PubMed ID: 30649227
[TBL] [Abstract][Full Text] [Related]
4. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
[TBL] [Abstract][Full Text] [Related]
5. Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy.
Huang J; Han C; Estacion M; Vasylyev D; Hoeijmakers JG; Gerrits MM; Tyrrell L; Lauria G; Faber CG; Dib-Hajj SD; Merkies IS; Waxman SG;
Brain; 2014 Jun; 137(Pt 6):1627-42. PubMed ID: 24776970
[TBL] [Abstract][Full Text] [Related]
6. The Novel Activity of Carbamazepine as an Activation Modulator Extends from Na
Han C; Themistocleous AC; Estacion M; Dib-Hajj FB; Blesneac I; Macala L; Fratter C; Bennett DL; Waxman SG; Dib-Hajj SD
Mol Pharmacol; 2018 Nov; 94(5):1256-1269. PubMed ID: 30135145
[TBL] [Abstract][Full Text] [Related]
7. The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability.
Han C; Vasylyev D; Macala LJ; Gerrits MM; Hoeijmakers JG; Bekelaar KJ; Dib-Hajj SD; Faber CG; Merkies IS; Waxman SG
J Neurol Neurosurg Psychiatry; 2014 May; 85(5):499-505. PubMed ID: 24006052
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of D623N variant and wild-type Na(v)1.7 sodium channels on resting potential and interspike membrane potential of dorsal root ganglion neurons.
Ahn HS; Vasylyev DV; Estacion M; Macala LJ; Shah P; Faber CG; Merkies IS; Dib-Hajj SD; Waxman SG
Brain Res; 2013 Sep; 1529():165-77. PubMed ID: 23850641
[TBL] [Abstract][Full Text] [Related]
9. A novel gain-of-function Na
Adi T; Estacion M; Schulman BR; Vernino S; Dib-Hajj SD; Waxman SG
Mol Pain; 2018; 14():1744806918815007. PubMed ID: 30392441
[TBL] [Abstract][Full Text] [Related]
10. Mutations in SCN3A cause early infantile epileptic encephalopathy.
Zaman T; Helbig I; Božović IB; DeBrosse SD; Bergqvist AC; Wallis K; Medne L; Maver A; Peterlin B; Helbig KL; Zhang X; Goldberg EM
Ann Neurol; 2018 Apr; 83(4):703-717. PubMed ID: 29466837
[TBL] [Abstract][Full Text] [Related]
11. Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H.
Vasylyev DV; Han C; Zhao P; Dib-Hajj S; Waxman SG
J Neurophysiol; 2014 Apr; 111(7):1429-43. PubMed ID: 24401712
[TBL] [Abstract][Full Text] [Related]
12. The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy.
Han C; Yang Y; de Greef BT; Hoeijmakers JG; Gerrits MM; Verhamme C; Qu J; Lauria G; Merkies IS; Faber CG; Dib-Hajj SD; Waxman SG
Neuromolecular Med; 2015 Jun; 17(2):158-69. PubMed ID: 25791876
[TBL] [Abstract][Full Text] [Related]
13. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
[TBL] [Abstract][Full Text] [Related]
14. Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States.
Jo S; Bean BP
Mol Pharmacol; 2017 Apr; 91(4):277-286. PubMed ID: 28119481
[TBL] [Abstract][Full Text] [Related]
15. Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7.
Estacion M; Han C; Choi JS; Hoeijmakers JG; Lauria G; Drenth JP; Gerrits MM; Dib-Hajj SD; Faber CG; Merkies IS; Waxman SG
Mol Pain; 2011 Dec; 7():92. PubMed ID: 22136189
[TBL] [Abstract][Full Text] [Related]
16. The insecticide deltamethrin enhances sodium channel slow inactivation of human Nav1.9, Nav1.8 and Nav1.7.
Bothe SN; Lampert A
Toxicol Appl Pharmacol; 2021 Oct; 428():115676. PubMed ID: 34389319
[TBL] [Abstract][Full Text] [Related]
17. Familial gain-of-function Na
Han C; Yang Y; Te Morsche RH; Drenth JP; Politei JM; Waxman SG; Dib-Hajj SD
J Neurol Neurosurg Psychiatry; 2017 Mar; 88(3):233-240. PubMed ID: 27503742
[TBL] [Abstract][Full Text] [Related]
18. The small fiber neuropathy NaV1.7 I228M mutation: impaired neurite integrity via bioenergetic and mitotoxic mechanisms, and protection by dexpramipexole.
Lee SI; Hoeijmakers JGJ; Faber CG; Merkies ISJ; Lauria G; Waxman SG
J Neurophysiol; 2020 Feb; 123(2):645-657. PubMed ID: 31851560
[TBL] [Abstract][Full Text] [Related]
19. Nonlinear effects of hyperpolarizing shifts in activation of mutant Na
Estacion M; Waxman SG
J Neurophysiol; 2017 Apr; 117(4):1702-1712. PubMed ID: 28148645
[TBL] [Abstract][Full Text] [Related]
20. Yield of peripheral sodium channels gene screening in pure small fibre neuropathy.
Eijkenboom I; Sopacua M; Hoeijmakers JGJ; de Greef BTA; Lindsey P; Almomani R; Marchi M; Vanoevelen J; Smeets HJM; Waxman SG; Lauria G; Merkies ISJ; Faber CG; Gerrits MM
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):342-352. PubMed ID: 30554136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
